BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23583640)

  • 1. Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK/T cell lymphoma cells.
    Takahara M; Nagato T; Komabayashi Y; Yoshino K; Ueda S; Kishibe K; Harabuchi Y
    Exp Hematol; 2013 Aug; 41(8):711-8. PubMed ID: 23583640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
    Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
    Int J Cancer; 2012 Jan; 130(1):48-58. PubMed ID: 21618217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.
    Yoshino K; Kishibe K; Nagato T; Ueda S; Komabayashi Y; Takahara M; Harabuchi Y
    Br J Haematol; 2013 Feb; 160(3):331-42. PubMed ID: 23206232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
    Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
    Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.
    Kanno H; Watabe D; Shimizu N; Sawai T
    Clin Exp Immunol; 2008 Mar; 151(3):519-27. PubMed ID: 18190605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.
    Harabuchi Y; Takahara M; Kishibe K; Moriai S; Nagato T; Ishii H
    Int J Clin Oncol; 2009 Jun; 14(3):181-90. PubMed ID: 19593607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
    Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells.
    Moriai S; Takahara M; Ogino T; Nagato T; Kishibe K; Ishii H; Katayama A; Shimizu N; Harabuchi Y
    Clin Cancer Res; 2009 Nov; 15(22):6771-9. PubMed ID: 19887486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.
    Takahara M; Nagato T; Kishibe K; Ueda S; Komabayashi Y; Yamashina M; Takahashi K; Harabuchi Y
    Hematol Oncol; 2017 Jun; 35(2):158-162. PubMed ID: 26563973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration cytology of CD56-positive natural killer/T-cell lymphoma of soft tissue.
    Cho EY; Gong G; Khang SK; Kang YK; Huh J
    Cancer; 2002 Dec; 96(6):344-50. PubMed ID: 12478682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.
    Nagato T; Ueda S; Takahara M; Kishibe K; Komabayashi Y; Kumai T; Ohara K; Hirata-Nozaki Y; Harabuchi S; Hayashi R; Ohkuri T; Bernasconi M; Nadal D; Kobayashi H; Harabuchi Y
    Lab Invest; 2019 May; 99(5):612-624. PubMed ID: 30664711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of extranodal NK/T-cell lymphoma of the nasal type diagnosed by nasal brush cytology.
    Kishimoto K; Kitamura T; Hirayama Y; Tate G; Mitsuya T
    Diagn Cytopathol; 2007 Feb; 35(2):125-9. PubMed ID: 17230578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study].
    Meneses-García A; Herrera J; Mohar A; García-Cuellar C; Súchil-Bernal L
    Gac Med Mex; 2005; 141(4):291-6. PubMed ID: 16164124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and significance of P53 and P21 in nasal NK/T-cell lymphoma].
    Xu G; Wang HF; He G; Xu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):132-6. PubMed ID: 20369488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
    Peh SC; Quen QW
    Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
    Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
    Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
    Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
    Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.
    Harabuchi Y; Takahara M; Kishibe K; Nagato T; Kumai T
    Front Pediatr; 2019; 7():141. PubMed ID: 31041299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.